Cellectis enters into strategic collaboration and investment agreement with AstraZeneca
Cellectis to receive up to $245M in cash, with potential for additional milestones, plus tiered royalties
03-Nov-2023 -
Cellectis announced it has entered into (i) a Joint Research Collaboration Agreement (the “Collaboration Agreement”, (ii) an investment agreement relating to an initial equity investment of $80M, and (iii) a memorandum of understanding (the “MOU”) relating to an additional equity investment of ...
cell therapies
gene editing
gene therapy
+3